Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma

Targeted Inhibition of FGF19/FGFR Cascade Improves Anti-Tumor Immunity and Response Rate in Hepatocellular Carcinoma

Hepatology International

Saved in:
Bibliographic Details
Main Author: Huynh The Hung
Other Authors: MEDICINE
Format: Article
Published: Hepatology International 2022
Subjects:
Preclinical study
liver cancer
PDX model
fibroblast growth factor signaling pathway
growth inhibition
drug resistance
metastasis
immune response
overall survival
vascular normalization
tumor hypoxia
Online Access:https://scholarbank.nus.edu.sg/handle/10635/230599
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:Hepatology International

Similar Items